Special Investment Situations (SIS) Newsletter Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Special Investment Situations (SIS) Newsletter

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Merrill Ericson who wrote (11)	3/27/1998 4:58:00 AM
From: WHL	of 18

Guess what?? CTIC has about $5.00 per share of CASH on hand, yet it is selling for about $4.00 per share. See CTIC's press release of Feb 23, 1998: cticseattle.com "As of December 31,1997, CTI had cash, cash equivalents, securities available-for-sale and collaboration agreement receivables totaling approximately $74.1 million, compared with approximately $31.0 million at December 31, 1996. CTI currently has approximately 15.4 million shares of common stock outstanding." Even if they had one clinical trial which was a loser, I don't think that justifies a stock price significantly discounted from their cash on hand!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next